Published in Am J Epidemiol on April 07, 2010
Circadian disrupting exposures and breast cancer risk: a meta-analysis. Int Arch Occup Environ Health (2014) 2.34
Breast cancer and circadian disruption from electric lighting in the modern world. CA Cancer J Clin (2013) 1.31
Shift work and cancer: the evidence and the challenge. Dtsch Arztebl Int (2010) 1.10
Circadian clocks and cell division: what's the pacemaker? Cell Cycle (2010) 1.10
Associations between rotating night shifts, sleep duration, and telomere length in women. PLoS One (2011) 1.07
Effect of circadian clock mutations on DNA damage response in mammalian cells. Cell Cycle (2012) 0.98
Total and cause-specific mortality of U.S. nurses working rotating night shifts. Am J Prev Med (2015) 0.93
Circadian genes and breast cancer susceptibility in rotating shift workers. Int J Cancer (2012) 0.90
The association between different night shiftwork factors and breast cancer: a case-control study. Br J Cancer (2013) 0.88
Night work and breast cancer in women: a Swedish cohort study. BMJ Open (2015) 0.87
Shift work, cancer and "white-box" epidemiology: Association and causation. Epidemiol Perspect Innov (2010) 0.87
Racial differences in the association between night shift work and melatonin levels among women. Am J Epidemiol (2013) 0.85
Circadian clock, cancer, and chemotherapy. Biochemistry (2014) 0.85
Re: "Night-shift work and breast cancer risk in a cohort of Chinese women". Am J Epidemiol (2010) 0.84
A retrospective cohort study of shift work and risk of cancer-specific mortality in German male chemical workers. Int Arch Occup Environ Health (2013) 0.83
Shift work and breast cancer among women textile workers in Shanghai, China. Cancer Causes Control (2014) 0.81
Occupational exposure and risk of breast cancer. Biomed Rep (2016) 0.81
Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies. J Natl Cancer Inst (2016) 0.80
Does current scientific evidence support a link between light at night and breast cancer among female night-shift nurses? Review of evidence and implications for occupational and environmental health nurses. Workplace Health Saf (2012) 0.80
Night work and breast cancer risk in a general population prospective cohort study in The Netherlands. Eur J Epidemiol (2014) 0.80
Individual variations in serum melatonin levels through time: implications for epidemiologic studies. PLoS One (2013) 0.80
Breast cancer risk and night shift work in a case-control study in a Spanish population. Eur J Epidemiol (2015) 0.80
Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature. Breast Care (Basel) (2014) 0.79
Nightshift work job exposure matrices and urinary 6-sulfatoxymelatonin levels among healthy Chinese women. Scand J Work Environ Health (2012) 0.78
Re: "Night-shift work and breast cancer risk in a cohort of Chinese women". Am J Epidemiol (2010) 0.77
The Nightingale study: rationale, study design and baseline characteristics of a prospective cohort study on shift work and breast cancer risk among nurses. BMC Cancer (2014) 0.76
Nighttime eating and breast cancer among Chinese women in Hong Kong. Breast Cancer Res (2017) 0.75
Shedding light on the role of circadian disruption in breast cancer etiology. Eur J Epidemiol (2016) 0.75
The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol (2005) 6.44
Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst (2001) 5.33
Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst (2001) 4.68
Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol (2007) 4.60
Increased breast cancer risk among women who work predominantly at night. Epidemiology (2001) 2.93
"Westernizing" women's risks? Breast cancer in lower-income countries. N Engl J Med (2008) 2.85
Light-at-night, circadian disruption and breast cancer: assessment of existing evidence. Int J Epidemiol (2009) 2.40
Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer (2005) 2.35
Night work and risk of breast cancer. Epidemiology (2006) 2.30
Nightshift work and risk of breast cancer and other cancers--a critical review of the epidemiologic evidence. Scand J Work Environ Health (2008) 2.10
Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control (1996) 1.64
Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat (2009) 1.49
Breast cancer and night work among Norwegian nurses. Cancer Causes Control (2006) 1.46
Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health (2007) 1.44
Shift work, light at night, and breast cancer on Long Island, New York. Am J Epidemiol (2006) 1.31
Genetic differences in human circadian clock genes among worldwide populations. J Biol Rhythms (2008) 1.27
Night work and breast cancer - results from the German GENICA study. Scand J Work Environ Health (2009) 1.21
What can the chronobiologist do to help the shift worker? J Biol Rhythms (2000) 1.14
Danish night shift workers with breast cancer awarded compensation. BMJ (2009) 0.98
Breast cancer on the night shift. Lancet (2009) 0.90
Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst (2004) 19.00
Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. Proc Natl Acad Sci U S A (2006) 9.92
Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet (2009) 8.44
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med (2013) 7.30
Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med (2011) 6.89
The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol (2005) 6.44
Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst (2008) 6.00
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
The Diesel Exhaust in Miners study: a nested case-control study of lung cancer and diesel exhaust. J Natl Cancer Inst (2012) 5.27
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet (2005) 5.01
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
Influence of exercise, walking, cycling, and overall nonexercise physical activity on mortality in Chinese women. Am J Epidemiol (2007) 4.63
High-throughput screening assays for the identification of chemical probes. Nat Chem Biol (2007) 4.50
Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet (2011) 4.50
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet (2016) 4.49
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors. Cancer Res (2011) 4.22
Hematotoxicity in workers exposed to low levels of benzene. Science (2004) 4.19
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin Cancer Res (2008) 4.02
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab (2004) 3.75
International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control (2008) 3.72
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Southern community cohort study: establishing a cohort to investigate health disparities. J Natl Med Assoc (2005) 3.67
Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol (2008) 3.60
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology (2003) 3.58
A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet (2010) 3.53
Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 3.51
SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res (2004) 3.47
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37
The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers. Cancer Res (2010) 3.16
Soy food intake and breast cancer survival. JAMA (2009) 3.16
Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst (2003) 3.07
The landscape of recombination in African Americans. Nature (2011) 3.06
A genetically defined model for human ovarian cancer. Cancer Res (2004) 3.02
Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. Cancer Epidemiol Biomarkers Prev (2002) 2.99
Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res (2008) 2.97
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet (2010) 2.96
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol (2010) 2.86
Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol (2011) 2.85
Environmental causes of esophageal cancer. Gastroenterol Clin North Am (2009) 2.80
Abdominal adiposity and mortality in Chinese women. Arch Intern Med (2007) 2.75
Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays. Assay Drug Dev Technol (2004) 2.74
Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol (2004) 2.73
Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A (2005) 2.72
Meta-analysis identifies common variants associated with body mass index in east Asians. Nat Genet (2012) 2.70
Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis. J Natl Cancer Inst (2008) 2.69
Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control (2006) 2.64
Identification of new genetic risk variants for type 2 diabetes. PLoS Genet (2010) 2.62
1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem (2007) 2.61
Manganese toxicity upon overexposure. NMR Biomed (2004) 2.61
A quantitative approach for estimating exposure to pesticides in the Agricultural Health Study. Ann Occup Hyg (2002) 2.60
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology (2012) 2.57